The number of people living with CKD worldwide rose from 378 million in 1990 to 788 million in 2023. Here is what is ...

Kidney cancer cases are rapidly increasing across the globe—and India has emerged as one of the top countries affected. The country currently ranks fourth in the world in terms of kidney cancer ...

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to ...

Kidney cancer treatment has shifted towards active surveillance and minimally invasive surgeries, improving patient outcomes and preserving kidney function. Robotic surgical techniques, including ...

Early-stage kidney cancer is often asymptomatic and discovered incidentally through imaging tests for unrelated conditions. Treatment options include partial nephrectomy, radical nephrectomy, ...

Patterns of "speckles" in the heart of tumor cells could help predict how patients with a common form of kidney cancer will respond to different treatment options, according to research. Nuclear ...

Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to diagnose. RCC is not easily distinguished ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

New research looked at how cancers arise in children who are predisposed to developing the childhood kidney cancer, Wilms tumor, which could help anticipate the development of tumors before they fully ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful immune ...

Forbes contributors publish independent expert analyses and insights. I am a physician and behavioral scientist at Duke University. Most normal people, when told they have kidney cancer, worry about ...